Abbonarsi

Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome - 07/11/23

Doi : 10.1016/j.clinre.2023.102220 
Annika Mutanen a, Mikko P Pakarinen a, b,
a Department of Pediatric Surgery, Pediatric Liver and Gut Research Group, Pediatric Research Center, The New Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland 
b Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden 

Corresponding author at: Stenbäckinkatu 11, PO Box 281, 00029 HUS, Helsinki, FinlandStenbäckinkatu 11, PO Box 281Helsinki00029 HUSFinland

Highlights

In SBS, enterohepatic circulation is interrupted due massive intestinal resection which associated with transcriptional evidence of increased hepatic synthesis and uptake of bile acids.
In PN dependent SBS patients with frequent hepatic cholestasis and inflammation, mRNA expression of transporters responsible for hepatic bile acid secretion was decreased.
Simultaneously increased hepatic synthesis and conservation of bile acids with impaired bile acid secretion may predispose to intestinal failure associated liver disease due to accumulation of bile acids in hepatocytes.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

Disturbed bile acid homeostasis may foster development of short bowel syndrome (SBS) associated liver disease during and after weaning off parenteral nutrition (PN). Our aim was to study hepatic molecular regulation of bile acid homeostasis in relation to serum and fecal bile acid profiles in pediatric SBS.

Methods

Liver histopathology and mRNA expression of genes regulating synthesis, uptake and export of bile acids, and cellular receptors involved in bile acid signaling were measured in SBS patients (n = 33, median age 3.2 years). Simultaneously, serum (n = 24) and fecal (n = 10) bile acid profiles were assessed. Sixteen patients were currently on PN. Results of patients were compared to healthy control subjects.

Results

Nine of ten (90 %) patients with histological cholestasis received current PN, while portal inflammation was present in 60 % (6/10) of patients with cholestasis compared to 13 % (3/23) without cholestasis (P = 0.01). In all SBS patients, hepatic synthesis and uptake of bile acids was increased. Patients on current PN showed widespread repression of hepatic FXR target genes, including downregulated canalicular (BSEP, MDR3) and basolateral (MRP3) bile acid exporters. Serum and fecal primary bile acids were increased both during and after weaning off PN.

Conclusions

Bile acid homeostasis in SBS is characterized by interrupted enterohepatic circulation promoting increased hepatic synthesis and conservation of bile acids. In PN dependent SBS patients with hepatic cholestasis and inflammation, the molecular fingerprint of downregulated hepatocyte canalicular and basolateral bile acid export with simultaneously increased synthesis and uptake of bile acids could favor their accumulation in hepatocytes and predispose to liver disease.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Canalicular bile transporter, Cholestasis, Intestinal failure associated liver disease, Parenteral nutrition, Pediatric intestinal failure

List of abbreviations : SBS, PN, IFALD, FXR (NR1H4), BSEP (ABCB11), ASBT (SLC10A2), qPCR, B2M, CA, CDCA, LCA, DCA, UDCA, ICV, GGT, APRI, CYP7A1, NTCP (SLC10A1), MRP3 (ABCC3), OATP1B1 (SLCO1B1), OSTβ (SLC51B), SHP (NR0B2), CYP8B1, CYP27A1, OATP1B3 (SLCO1B3), MDR3 (ABCB4), CYP8B1, FGFR4, KLB, FGF19, VDR (NR1I1), PPRA (NR1C1), NR3C1 (GR), FGF21, C4, MRP2 (ABCC2), MRP4 (ABCC4), OSTα (SLC51A), PXR (NR1I2), GR (NR3C1), TGR5 (GPBAR1)


Mappa


© 2023  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 47 - N° 9

Articolo 102220- Novembre 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Maternal and prenatal outcomes of hemochromatosis in pregnancy: A population-based study
  • Chengu Niu, Jing Zhang, Ido Goldenberg, Simrat Gill, Hassan Saeed, Charoo Iyer, Karin Dunnigan
| Articolo seguente Articolo seguente
  • Complete response with sorafenib after immune-induced hepatitis with atezolizumab/bevacizumab for advanced hepatocellular carcinoma, synergic effect?
  • Manon Evain, Isabelle Galy-Fauroux, Joana Araujo-Goncalves, Frédéric Charlotte, Jean Pierre Couty, Manon Allaire

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.